CORTEXA
← Browse
openalexFrontiers in Immunology2026-07-24Cited by 0

Non-redundant functions of NFATc1 in survival and NFATc2 in generation of exhausted CD8+ T cells

Salvador Sampere-Birlanga, Stefan Klein‐Hessling, Miriam Campillo Prados, Anfei Huang, Hao Wu, Andreas Rosenwald, Wolfgang Kastenmüller, Edgar Serfling, Martin Vaeth, Friederike Berberich‐Siebelt

Persistent antigenic stimulation leads to the dysfunction of CD8 + cytotoxic T cells. These “exhausted” T EX cells exhibit reduced proliferative capacity, impaired effector function, and increased expression of co-inhibitory receptors. Chronic antigen receptor stimulation induces the expression of NFATc1/αA, a short isoform of NFATc1 that promotes T EX cell survival. The induction of NFATc1/αA is accompanied by a significant decrease in NFATc2 expression. NFATc2 limits the expression of stemness-associated genes, such as Tcf7 , Sell , and Id3. It also supports the expression of Prf1 , Gzmb , and the T EX marker gene Havcr2 . Therefore, ablation of NFATc2 mitigates functional exhaustion of CD8 + T cells during chronic viral infection and antitumor immunity. Our findings illustrate that NFATc1 promotes the survival of T EX cells, while NFATc2 promotes the terminal differentiation and dysfunction of exhausted CD8 + T cells. The data suggest a non-redundant interplay between NFATc1 and NFATc2, each playing a distinct role in controlling CD8 + T-cell exhaustion. These findings open novel avenues to enhance the efficacy of immune checkpoint and CAR T-cell therapies.

View free PDFSource page

Related papers

openalexFrontiers in Immunology2026-07-23

A low-dose immunotherapy targeting Fc gamma Receptors and heparan sulfate proteoglycan to impact myeloid cells and control cancers with diverse immunosuppressive profiles

Nora Kakwata-Nkor Deluce, Elodie Creton, Alexandra Savatier, Honorine Lucchi, Laureen Bardouillet, Oscar Pereira Ramos, et al.

Myeloid cells play a key role in cancer-associated immunosuppression because their accumulation and reprogramming inhibit antitumor responses and support tumor growth. To modulate their activity, we targeted Fcγ receptors (FcγRs), which are broadly expressed in myeloid subsets. S…

View free PDFSource page
openalexFrontiers in Immunology2026-07-23

Metabolic immune checkpoints in cancer: how tumor-derived metabolites shape immunotherapy resistance

Renjie Pan, Dongdong Chen, Y X Wu, 张兰成, J B Zhang, Junjie Li, et al.

Immune checkpoint blockade has transformed cancer therapy, yet many tumors remain intrinsically resistant or acquire resistance after initial response. Increasing evidence indicates that this failure is not determined solely by PD-1, PD-L1, CTLA-4, or T-cell exhaustion, but also…

View free PDFSource page
openalexFrontiers in Immunology2026-07-24

Structural quality-tier assessment for TCR-pMHC functional enrichment

Alex Ascunce-París, Miguel Romero‐Durana, Alfonso Valencia, Roc Farriol-Duran, Vı́ctor Guallar

T cell receptor (TCR) recognition of peptide-MHC complexes (pMHCs) is central to adaptive immunity. Structural insights into TCR-pMHC interactions are critical for understanding antigen specificity and T-cell function. However, progress remains limited by the scarcity of experime…

View free PDFSource page
openalexFrontiers in Immunology2026-07-23

Dual-targeting CD73/PD-L1 bifunctional inhibitor: a promising cancer immunotherapy strategy

Jing-Jing Du, Sen Wu, Shiyun Cheng, Xiaobo Zeng, Binbin Cheng

Objectives This work aims to design and characterize a novel bifunctional small molecule that simultaneously targets PD-L1 and CD73 to enhance the therapeutic efficacy of tumor immunotherapy. Methods Multiple methodologies were integrated for compound screening and biological cha…

View free PDFSource page
openalexFrontiers in Immunology2026-07-23

Immunosenescence in prostate cancer: from aging-related immune dysfunction to therapeutic opportunities

Juntao Guo, Ke Wu, Zheng M, Guo S, Fang Wang, Lingxiang Lu

Prostate cancer is a typical age-associated malignancy, and increasing evidence suggests that age-related immune alterations play an important role in its initiation, progression, and therapeutic response. Immunosenescence, characterized by impaired immune surveillance, reduced e…

View free PDFSource page
openalexFrontiers in Immunology2026-07-23

Generation and characterization of an anti ITGB4 monoclonal antibody that blocks Zika virus entry

X D Han, Weiwei Li, Shuqian Yang, Yancun Gong, Jie Shen, Lei Song, et al.

Introduction Zika virus (ZIKV) causes congenital disease and neurological complications, yet no approved vaccines or antivirals are available. Integrin β4 (ITGB4) has been identified as an entry receptor for ZIKV. Methods Recombinant human ITGB4 ectodomain was expressed using a b…

View free PDFSource page